Article
More permanent solution for correcting presbyopia possible, with betternear, distance vision
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Innovent Biologics completes first patient dosing in its phase 2 clinical trial assessing efdamrofusp alfa in patients with DME
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Assessment of AI-enabled screening for ROP in low-resource settings
First patient dosed in VAN-2401 phase 1 clinical trial